Table 1 Summary of demographics and clinical variables at baseline
CR (n = 36) | PE (n = 34) | P | |
|---|---|---|---|
Gender (n/% females) | 28/77.8 | 24/70.6 | n.s. |
Age | 32.4 (6.04) | 32.8 (8.8) | n.s. |
Years of education | 11.78 (4.12) | 11.0 (3.33) | n.s. |
Sick-leave/Unemployed (n/%) | 16/44.4 | 13/38.2 | n.s. |
DIB-R | 7.65 (1.35) | 7.33 (1.31) | n.s. |
GAF | 54.74 (7.45) | 56.03 (8.94) | n.s. |
CGI-BPD | 4.94 (0.79) | 4.74 (0.93) | n.s. |
Pharmacological treatment (n/%) | 27 (75) | 23 (67.6) | n.s. |
Antidepressant | 24 (66.7) | 22 (64.7) | n.s. |
Benzodiazepine | 16 (44.4) | 13 (38.2) | n.s. |
Mood Stabilizer | 20 (55.6) | 13 (38.2) | n.s. |
Antipsychotic | 11 (30.6) | 11 (32.4) | n.s. |